The American College of Physicians today issued a guidance statement for routine colorectal cancer screening for average-risk adults.
The worst state for drug sales on school grounds? The best state for detox and rehab facilities? Test your best guess with these and 6 more best/worst comparisons.
Screening for depression among ACS patients is widely recommended by professional guidelines, but a new study suggests little return on the investment.
The SGLT2 inhibitor, on October 21, 2019 was granted a label expansion from FDA for the prevention of hospitalization for heart failure in patients with T2D.
Lasmitidan is the first 5-HT1F receptor agonist to receive FDA approval and was found superior to placebo for reduction of migraine pain and most bothersome symptom at 2 hours.
Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.
For people with type 2 diabetes, receiving motivational messages via mobile text was associated with reduced A1c vs patients who received usual care.
CVS, Walgreens, and Rite Aid have all taken branded and generic ranitidine products off shelves as FDA continues to investigate contamination with a suspected carcinogen.
The CDC made important changes to its flu vaccination recommendations for 2019-2020. Here is a quick review.
The SGLT-2 inhibitor canagliflozin was FDA-approved on September 30, 2019, to slow progression of diabetic kidney disease and reduce risk of heart failure hospitalization.